Links

Homepage

Stock List

Search by Ticker

News

Login

Hologic (NASDAQ:HOLX)
Stock Analysis

HOLX65.695
▼ -0.31%-0.205

Stock Analysis

The following stock analysis is based on 8 years of data (i.e. since Aug 03, 2012). All the stock history has been downloaded.

Stock Exchange

Hologic trades on the NasdaqGS exchange in USD dollars.

Sector

It is in the healthcare sector.

Current Status of Hologic

It is currently trading at $65.695 ($65.9 the previous day).

Financials

The next reporting date is in 84 days (2020 11 04).

CNN estimates profits for the upcoming quarter will be $1.06 per share ($989.0M). The current Canada / US exchange rate is 1.32892.



Over the past 12 months, $0 worth of shares have been purchased and $36967653 worth of shares have been sold by insiders.

Will This Trend Continue?

The year over year average increase is 10.7% per year assuming steady exponential growth. The actual 5 year average is 10.72. Details on the individual increase in one year intervals is provided below.

Past PerformanceAverage PricePercent Change
1 year50.32505376344115.3+ Above Average
2 year43.65296943231410.1- Below Average
3 year39.648529411765-3.4- Below Average
4 year41.03575510204111.3+ Above Average
5 year36.88003802281420.3+ Above Average
Hologic is projected by analysts to get to $78.00 within the next 12 months (18.7%), but preticted targets range from as high as $84.00 (27.9%) and as low as $68(3.5%).

Risk

The worst drop it has had in recent years is -45.9%. It has a few bumps shape to the stock curve, which means the stock generally continues on a consistent trend and does not have to be checked often, but can have some variation during periods of volitility.

Stock shape test

DAYS AG0PRICE
1062.1RISING
3057.86RISING
6052.75RISING
15045.82RISING
36550.06DROPPING
80037.89RISING
120044.6DROPPING
160034.99RISING
200030.46RISING


With an average increase of 10.7% year over year, if Hologic is bought at the worst time, Stockmarketizer analysts estimate it will take 51.5 months before the stock will recover to the original purchase price. The P/E value is 35.21. The stock is under valued as the industry standard in the healthcare sector is a P/E of 86.26.

Tradingview BuySell Widget

Yahoo News Feed

Syneos Health (SYNH) Q2 Earnings Top Estimates, Margins Down

Tue, 11 Aug 2020 13:50:01 Syneos Health (SYNH) wins 35 COVID-19 related projects through the second quarter.... Read Full Article

Hologic Launches Validated Pooling Protocol for COVID-19 Testing

Tue, 11 Aug 2020 12:02:00 Hologic Launches Validated Pooling Protocol for COVID-19 Testing... Read Full Article

Integra (IART) Q2 Earnings Surpass Estimates, Margins Fall

Tue, 11 Aug 2020 11:15:11 Integraand's (IART) second-quarter 2020 results reflect disappointing segmental performance due to coronavirus-led business disruptions.... Read Full Article

Globus Medical (GMED) Beats Q2 Earnings andand Revenue Estimates

Mon, 10 Aug 2020 12:20:12 Globus Medical (GMED) witnesses dismal segmental and international performance in the second quarter owing to pandemic-led adversities.... Read Full Article

Braveheart Resources Inc. Issues Retraction to News Release Dated August 6, 2020

Fri, 07 Aug 2020 18:57:00 Calgary, Alberta--(Newsfile Corp. - August 7, 2020) - Braveheart Resources Inc. (TSXV: BHT) (OTCQB: RIINF) (and"Braveheartand" or the and"Companyand"). At the request of the Investment Industry Regulatory Organization of Canada, the Company hereby retracts a statement made in its ...... Read Full Article

Braveheart Resources Inc. Closes $101,500 First Tranche from Alumina Financing Facility

Thu, 06 Aug 2020 20:22:00 Calgary, Alberta--(Newsfile Corp. - August 6, 2020) -  Braveheart Resources Inc. (TSXV: BHT) (OTCQB: RIINF) (and"Braveheartand" or the and"Companyand") is pleased to announce that it has closed a first tranche of $101,500 from a financing facility with Alumina Partners (Ontario) ...... Read Full Article

NuVasiveand's (NUVA) Q2 Earnings Beat Estimates, Revenues Miss

Thu, 06 Aug 2020 14:21:02 NuVasiveand's (NUVA) operating segments experienced slowdown in second-quarter volumes due to the coronavirus pandemic.... Read Full Article

Why Hologic (HOLX) Could Be Positioned for a Surge

Thu, 06 Aug 2020 12:32:12 Hologic (HOLX) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.... Read Full Article

CVS Health (CVS) Q2 Earnings Top Estimates, 2020 View Up

Wed, 05 Aug 2020 16:01:04 CVS Healthand's (CVS) Health Care Benefits segment registers membership growth in Q2.... Read Full Article

Intersect ENT (XENT) Q2 Loss Widens, Revenues Beat Estimates

Wed, 05 Aug 2020 14:34:02 Although Intersect ENTand's (XENT) Q2 sales are down year over year, itand's stronger than expected, led by the return of sinus surgery procedures using PROPEL.... Read Full Article

Haemonetics (HAE) Q1 Earnings Beat Estimates, Margins Down

Wed, 05 Aug 2020 13:52:01 Haemoneticsand' (HAE) first-quarter fiscal 2021 results reflect impressive performance by Blood Center segment despite dismal overall performance during the coronavirus-led crisis.... Read Full Article

Zimmer Biometand's (ZBH) Q2 Earnings Beat, Margins Contract

Tue, 04 Aug 2020 15:40:03 Zimmer Biometand's (ZBH) second-quarter elective procedure volumes decline across all regions.... Read Full Article

Bruker (BRKR) Q2 Earnings Surpass Estimates, Margins Fall

Tue, 04 Aug 2020 14:40:02 Brukerand's (BRKR) second-quarter 2020 results reflect dismal performance by all segments and geographies due to coronavirus-led business disruptions.... Read Full Article

STERISand' (STE) Earnings andand Revenues Surpass Estimates in Q1

Tue, 04 Aug 2020 14:28:02 STERISand' (STE) first-quarter fiscal 2021 results reflect strong performance by the Life Sciences segment despite the coronavirus-led economic crisis.... Read Full Article

Hologic Announces ‘Back to Screening’ Campaign Encouraging Women to Prioritize Mammograms Delayed due to COVID-19 Pandemic

Mon, 03 Aug 2020 12:08:00 Hologic Announces ‘Back to Screening’ Campaign Encouraging Women to Prioritize Mammograms Delayed due to COVID-19 Pandemic... Read Full Article

New Cervical Cancer Screening Guidelines from the American Cancer Society Risk Reversing Decades of Progress Made Against Cervical Cancer

Fri, 31 Jul 2020 12:00:00 New Cervical Cancer Screening Guidelines from the American Cancer Society Risk Reversing Decades of Progress Made Against Cervical Cancer... Read Full Article

Analysts Just Published A Bright New Outlook For Hologic, Inc.and's (NASDAQ:HOLX)

Fri, 31 Jul 2020 10:54:37 Hologic, Inc. (NASDAQ:HOLX) shareholders will have a reason to smile today, with the analysts making substantial...... Read Full Article

Hologic (HOLX) Q3 Earnings Surpass Estimates, Margins Rise

Thu, 30 Jul 2020 13:20:01 Hologic (HOLX) exhibited robust segmental growth in third-quarter fiscal 2020 driven by strong performance by the Diagnostics segment amid the coronavirus pandemic.... Read Full Article

Hologic Inc (HOLX) Q3 2020 Earnings Call Transcript

Thu, 30 Jul 2020 04:03:39 HOLX earnings call for the period ending June 30, 2020.... Read Full Article

Recap: Hologic Q3 Earnings

Wed, 29 Jul 2020 21:47:57 Shares of Hologic (NASDAQ:HOLX) were unchanged in after-market trading after the company reported Q3 results.Quarterly Results Earnings per share were up 19.05% over the past year to $0.75, which beat the estimate of $0.37.Revenue of $822,900,000 decreased by 3.46% year over year, ...... Read Full Article
<